Focus on Cervicovaginal Health: Microbiome, Sexually Transmitted Infections, and Beneficial Microbes: 2nd Edition

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Epidemiology of Infectious Diseases".

Deadline for manuscript submissions: 31 July 2025 | Viewed by 2087

Special Issue Editors


E-Mail Website
Guest Editor
Department of Experimental, Diagnostic and Specialty Medicine—DIMES, University of Bologna, Bologna 40138, Italy
Interests: genital microbiota and interactions between health promoting bacteria (as lactobacilli) and pathogens; laboratory diagnosis of sexually transmitted diseases and maternal-foetal infections; epidemiology of the main bacterial sexually transmitted infections; role of Chlamydia pneumoniae infection in inducing a dyslipidemic effect in experimental models
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Experimental, Diagnostic and Specialty Medicine—DIMES, University of Bologna, Bologna 40138, Italy
Interests: bacterial sexually transmitted infections; Chlamydia trachomatis; vaginal microbiome; lactobacilli; host-pathogen interactions; metabolomics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The cervicovaginal ecosystem is made up of diverse microorganisms coexisting in a dynamic balance and establishing complex connections with each other and with the host. In healthy reproductive-aged women, the vaginal microbiome generally shows a predominance of lactobacilli. Lactobacilli promote the maintenance of the vaginal homeostasis and prevent the colonization and growth of adverse microorganisms (e.g., Candida spp., anaerobes associated with bacterial vaginosis), including those responsible for sexually transmitted infections (e.g., Chlamydia trachomatis, Neisseria gonorrhoeae). Such defensive function is exerted through various mechanisms, such as vaginal pH lowering, bioactive compound production, competition for nutrients and adhesion sites, and modulation of the host immune response. However, the composition of the vaginal microbiome can vary throughout a woman’s life in response to endogenous and exogenous factors, such as age, pregnancy, pharmaceutical treatments, and urogenital infections.

Understanding the pathophysiology of the vaginal microbiota is crucial for maintaining the health and functioning of the female genital tract, in terms of novel biomarker discovery and development of new therapeutic approaches.

This Special Issue will cover a wide range of topics focusing on vaginal health: composition and functioning of the cervicovaginal microbiome in normal and pathological conditions, interactions between ‘health-promoting’ microorganisms and urogenital pathogens, discovery of new vaginal biomarkers in healthy status and dysbiosis, epidemiology and risk factors of common genital disorders (bacterial vaginosis, STIs, vulvovaginal candidiasis), animal models on the vaginal microenvironment, and innovative antimicrobial-free treatments for urogenital infections.

This Special issue aims to help to enhance current knowledge on the role and functioning and of the cervicovaginal microbial niche. All types of articles will be considered for publication, including short reports, primary research articles, and reviews.

We look forward to your contribution.

Dr. Antonella Marangoni
Dr. Claudio Foschi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaginal microbiome
  • vaginal metabolome
  • lactobacilli
  • host–pathogen interactions
  • sexually transmitted infections
  • Chlamydia
  • gonorrhea
  • vaginal dysbiosis
  • vulvovaginal candidiasis
  • animal models

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1913 KiB  
Article
Synergistic Inhibition of Candida albicans by Cranberry Proanthocyanidins and Probiotics: Novel Strategies for Vulvovaginal Candidiasis Treatment
by Yu-Ru Wu, Jung-Sheng Chen, Lei-Chin Chen, Laura Chen, Yu-Fen Huang and Chien-Sen Liao
Pathogens 2025, 14(4), 308; https://doi.org/10.3390/pathogens14040308 - 24 Mar 2025
Viewed by 372
Abstract
Vulvovaginal candidiasis (VVC) is a common gynecological condition primarily caused by Candida albicans. The excessive use of antifungal drugs has led to increased drug resistance, necessitating the search for alternative therapies. This study investigates the synergistic antifungal effects of cranberry proanthocyanidins (PACs) [...] Read more.
Vulvovaginal candidiasis (VVC) is a common gynecological condition primarily caused by Candida albicans. The excessive use of antifungal drugs has led to increased drug resistance, necessitating the search for alternative therapies. This study investigates the synergistic antifungal effects of cranberry proanthocyanidins (PACs) and probiotics against C. albicans. PACs were prepared at different concentrations (low, medium, high) and tested alone and in combination with multi-strain probiotics, including Lactobacillus rhamnosus and Lactobacillus plantarum. The antifungal activity of their cell-free supernatants (CFS) was also assessed. The results demonstrated that the combination of L. plantarum and medium-concentration PACs (L.p. + PACs M) significantly enhathe inhibitionition of C. albicans compared to individual treatments. In the Vaginal Microbiota Communities Analysis, this condition reduced C. albicans relative abundance to below 0.01%. This study highlights the potential of natural compounds and probiotics as alternative therapeutic strategies for VVC. Full article
Show Figures

Graphical abstract

11 pages, 294 KiB  
Article
Are Chlamydia Trachomatis and Neisseria Gonorrhoeae Screenings in Pregnant Women Being Properly Performed? A Single-Center Retrospective Observational Study in Italy
by Vito Mondì, Jacopo Caravetta, Piermichele Paolillo, Nicola Salce, Chryssoula Tzialla, Barbara Vasapollo, Herbert Valensise, Manuela Bedetta and Simonetta Picone
Pathogens 2024, 13(7), 570; https://doi.org/10.3390/pathogens13070570 - 8 Jul 2024
Cited by 1 | Viewed by 1287
Abstract
A new Italian intersociety position statement on the prevention of ophthalmia neonatorum was published in 2023. In this document, attention was paid to the indications for the screening of gonococcal and chlamydial infections during pregnancy according to the international and national guidelines for [...] Read more.
A new Italian intersociety position statement on the prevention of ophthalmia neonatorum was published in 2023. In this document, attention was paid to the indications for the screening of gonococcal and chlamydial infections during pregnancy according to the international and national guidelines for the prevention of sexually transmitted infections (STIs). We conducted an observational retrospective study to assess whether the current guidelines for the prevention of STIs are being followed correctly. From February to August 2022, 2507 women nearing childbirth were enrolled. Among them, 42.4% received a swab for Chlamydia and only 0.5% for gonococcus. Concerning the geographical area of origin, most of the screened women came from Western Europe. None of the women who received gonococcal swabs and only 105 women out of 1062 screened for Chlamydia were under 25 years of age. Overall, only seven swabs were positive for Chlamydia, while none were positive for gonococcus. Concerning the age, geographical area of origin, and medical history of the women with a positive screening for Chlamydia, all were over 25 years old, six were from Western Europe, one was from South America, and none had other STIs. Although monocentric in nature, this study shows that the guidelines are not being followed correctly. Full article
Back to TopTop